Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.41 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | GABRP | O00591 | 2/20 | 0.33 |
| ▸ | GABRD | O14764 | 2/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.33 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.33 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.33 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.33 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.33 |
| ▸ | GABRE | P78334 | 2/20 | 0.33 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.33 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.33 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20284332 | 1.00 | OPRM1 (0.42) | OPRM1PLA2G1BPLA2G2ASIGMAR1ALDH1A1 | |
| SCHEMBL29587619 | 0.94 | OPRM1 (0.42) | OPRM1PLA2G1BPLA2G2ASIGMAR1ALDH1A1 | |
| SCHEMBL1272725 | 0.85 | OPRM1 (0.41) | OPRM1PLA2G1BPLA2G2AALDH1A1GABRP | |
| SCHEMBL3856955 | 0.84 | OPRM1 (0.50) | OPRM1PLA2G1BPLA2G2ASIGMAR1ALDH1A1 | |
| SCHEMBL3856709 | 0.84 | OPRM1 (0.50) | OPRM1PLA2G1BPLA2G2ASIGMAR1ALDH1A1 | |
| SCHEMBL29881540 | 0.84 | OPRM1 (0.50) | OPRM1PLA2G1BPLA2G2ASIGMAR1ALDH1A1 | |
| SCHEMBL417108 | 0.84 | OPRM1 (0.50) | OPRM1PLA2G1BPLA2G2ASIGMAR1ALDH1A1 | |
| SCHEMBL12074464 | 0.84 | PLA2G1B (0.35) | OPRM1PLA2G1BPLA2G2A | |
| SCHEMBL4708786 | 0.82 | OPRM1 (0.54) | OPRM1PLA2G1BPLA2G2ASIGMAR1ALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL17473691 | 0.82 | OPRM1 (0.48) | OPRM1PLA2G1BPLA2G2ASIGMAR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106458883-A | Chlorine resistant polyethylene compounds and articles made therefrom | 弗纳技术股份有限公司 | 2017-02-22 | — | — | CN | claimed |
| CN-103108918-B | Method for manufacturing resin for thiourethane-based optical material using universal polyisocyanate compound, resin composition, and optical material manufactured thereby | KOC SOLUTION CO LTD | 2015-07-15 | — | — | CN | claimed |
| CN-103108918-A | Method for manufacturing resin for thiourethane-based optical material using universal polyisocyanate compound, resin composition, and optical material manufactured thereby | KOC SOLUTION CO LTD | 2013-05-15 | — | — | CN | claimed |
| US-20020058788-A1 | Facile deprotection of Fmoc protected amino groups | DISCOVERY PARTNERS INTERNATIONAL, INC. | 2002-05-16 | — | — | US | claimed |
| EP-3351538-A1 | TRIAZINE COMPOUNDS AND COMPOSITIONS THEREOF AND METHODS FOR TREATING MALARIA AND CHEMOPROPHYLAXIS | The United States of America, as represented by The Secretary of The Army, on behalf of Walter Reed Army Institute of Research (US) | 2018-07-25 | — | — | EP | disclosed |
| EP-2970153-B1 | TRIAZINE COMPOUNDS AND COMPOSITIONS THEREOF AND METHODS FOR TREATING MALARIA AND CHEMOPROPHYLAXIS | THE US SECRETARY OF THE ARMY ON BEHALF OF WALTER REED ARMY INSTITUTE OF RESEARCH (US) | 2018-02-21 | — | — | EP | disclosed |
| US-9700562-B2 | Triazine compounds and compositions thereof and methods for treating malaria and chemoprophylaxis | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE ARMY, ON BEHALF OF THE WALTER REED ARMY INSTITUTE OF RESEARCH (US) | 2017-07-11 | — | — | US | disclosed |
| US-20160340313-A1 | COMPOUNDS, COMPOSITIONS AND ASSOCIATED METHODS COMPRISING 3-ARYL QUINOLINES | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2016-11-24 | — | — | US | disclosed |
| US-20160213675-A1 | Triazine Compounds and Compositions Thereof and Methods for Treating Malaria and Chemoprophylaxis | WALTER REED ARMY INST OF RES THE USA AS REPRESENTED BY THE SEC OF THE ARMY ON BEHALF OF THE (US) | 2016-07-28 | — | — | US | disclosed |
| US-9334246-B2 | Substituted triazines for malaria treatment and chemoprophylaxis | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE ARMY, ON BEHALF OF THE WALTER REED ARMY INSTITUTE OF RESEARCH (US) | 2016-05-10 | — | — | US | disclosed |
| WO-2016044585-A1 | ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF | Epizyme, Inc. (US) | 2016-03-24 | — | — | WO | disclosed |
| US-20150210652-A1 | Substituted Triazines for Malaria Treatment and Chemoprophylaxis | THE GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2015-07-30 | — | — | US | disclosed |
| US-20020103381-A1 | Method for the synthesis of pyrazolines | CHEMRX ADVANCED TECHNOLOGIES, INC. | 2002-08-01 | — | — | US | disclosed |
| US-20020058788-A1 | Facile deprotection of Fmoc protected amino groups | DISCOVERY PARTNERS INTERNATIONAL, INC. | 2002-05-16 | — | — | US | disclosed |
| WO-2001060798-A1 | AMINE DERIVATIVES FOR THE TREATMENT OF APOPTOSIS | APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) | 2001-08-23 | — | — | WO | disclosed |
| EP-1075261-A1 | MYCOBACTERIAL INHIBITORS | AstraZeneca AB (SE) | 2001-02-14 | — | — | EP | disclosed |
| WO-1999065483-A1 | MYCOBACTERIAL INHIBITORS | ASTRAZENECA AB (SE) | 1999-12-23 | — | — | WO | disclosed |
| US-4676803-A | Reactive azo dyestuffs, free from anionic groups and containing a basic group and halogenotriazinyl radical and useful for dyeing cellulose/polyester | BAYER AKTIENGESELLSCHAFT (DE) | 1987-06-30 | — | — | US | disclosed |
| US-4503224-A | FIBER-REACTIVE, COTTON-POLYESTER BLENDS | BAYER AKTIENGESELLSCHAFT (DE) | 1985-03-05 | — | — | US | disclosed |
| EP-0022209-A2 | Fluor-triazine dyestuffs and their use in dyeing cellulosic fibrous materials | BAYER AG (DE) | 1981-01-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160340313-A1 | COMPOUNDS, COMPOSITIONS AND ASSOCIATED METHODS COMPRISING 3-ARYL QUINOLINES | CYP3A43, ABL1, CYP3A7 | OPRM1 2580/4885PLA2G1B 2776/4885PLA2G2A 2207/4885 |
| US-20150210652-A1 | Substituted Triazines for Malaria Treatment and Chemoprophylaxis | CYP3A5, HCCS, COX15 | OPRM1 2648/4885PLA2G1B 4141/4885PLA2G2A 4457/4885 |
| US-20020103381-A1 | Method for the synthesis of pyrazolines | CYP2F1, CYP2E1, CYP3A7 | OPRM1 2663/4885PLA2G1B 3663/4885PLA2G2A 4370/4885 |
| US-20020058788-A1 | Facile deprotection of Fmoc protected amino groups | DNPEP, LNPEP, NPEPPS | OPRM1 2113/4885PLA2G1B 4427/4885PLA2G2A 4681/4885 |
| US-20160213675-A1 | Triazine Compounds and Compositions Thereof and Methods for Treating Malaria and Chemoprophylaxis | HCCS, CYP3A5, COX15 | OPRM1 3324/4885PLA2G1B 3403/4885PLA2G2A 3887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.